Related references
Note: Only part of the references are listed.Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study
Michael Manz et al.
BMC GASTROENTEROLOGY (2012)
Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study
D. Laharie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study
Lamia Kallel et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Fecal Calprotectin Variability in Crohn's Disease
Bjorn Moum et al.
INFLAMMATORY BOWEL DISEASES (2010)
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
Valle Garcia-Sanchez et al.
JOURNAL OF CROHNS & COLITIS (2010)
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
Patrick F. van Rheenen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease
J. P. Gisbert et al.
DIGESTIVE AND LIVER DISEASE (2009)
Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2009)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
Jennifer Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Review of fecal biomarkers in inflammatory bowel disease
Andrew D. Sutherland et al.
DISEASES OF THE COLON & RECTUM (2008)
Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease
Michael Wagner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy
Alexander C. von Roon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
F Costa et al.
GUT (2005)
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
AG Roseth et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
CB Summerton et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
A simple method for assessing intestinal inflammation in Crohn's disease
J Tibble et al.
GUT (2000)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
JA Tibble et al.
GASTROENTEROLOGY (2000)
Share Paper
